{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:05:42Z","timestamp":1789596342573,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Radiofrequency ablation (RFA) of leiomyomas represents a significant advancement in the treatment of this common uterine condition. In the appropriately selected patient, both laparoscopic and transcervical options provide effective treatment for bleeding and bulk symptoms in a uterine-sparing manner. Compared with other minimally invasive leiomyoma treatment options, RFA procedures have comparable or favorable safety profiles, recovery timelines, and reintervention rates. Data on future fertility and pregnancy are limited, although early reports are promising.<\/jats:p>","DOI":"10.1097\/aog.0000000000005196","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:06:58Z","timestamp":1681405618000},"page":"1063-1071","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Radiofrequency Ablation of Leiomyomas"],"prefix":"10.1097","volume":"141","author":[{"given":"Kelsey A.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Cohen Rassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder","year":"1965","journal-title":"Science"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Day Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/AOG.0000000000005053","article-title":"Use of conservative therapies before hysterectomy for uterine leiomyomas","volume":"141","author":"Liao","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0039-6060(96)80137-1","article-title":"Bovie and electrosurgery","volume":"119","author":"O'Connor","year":"1996","journal-title":"Surgery"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00004424-199003000-00011","article-title":"Hepatic ablation using radiofrequency electrocautery","volume":"25","author":"McGahan","year":"1990","journal-title":"Invest Radiol"},{"key":"R8-20260916","first-page":"9S","article-title":"Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative [abstract]","volume":"99","author":"Lee","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.jvir.2010.04.008","article-title":"Radiofrequency ablation: mechanism of action and devices","volume":"21","author":"Hong","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/0-387-29512-7_8","article-title":"Electrodes and multiple electrode systems for radio frequency ablation: a proposal for updated terminology","volume":"574","author":"Mulier","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/IJWH.S119265","article-title":"Surgeons\u2019 early experience with the AcessaTM procedure: gaining proficiency with new technology","volume":"8","author":"Braun","year":"2016","journal-title":"Int J Womens Health"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/lap.2019.0550","article-title":"Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies","volume":"29","author":"Bradley","year":"2019","journal-title":"J Laparoendoscopic Adv Surg Tech"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e31828b7962","article-title":"Outpatient procedure for the treatment and relief of symptomatic uterine myomas","volume":"121","author":"Chudnoff","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmig.2018.09.772","article-title":"Quality of life, adverse events, and reintervention outcomes after laparoscopic radiofrequency ablation for symptomatic uterine fibroids: a meta-analysis","volume":"26","author":"Lin","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jmig.2022.06.006","article-title":"Postoperative uterine necrosis and peritonitis following laparoscopic radiofrequency myoma ablation","volume":"29","author":"Lin","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/uog.11118","article-title":"Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity","volume":"40","author":"Iversen","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jmig.2022.01.009","article-title":"Clinical and patient reported outcomes of pre- and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy","volume":"29","author":"Yu","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"Br\u00f6lmann","year":"2016","journal-title":"Gynecol Surg"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/AOG.0000000000003032","article-title":"Ultrasound-guided transcervical ablation of uterine leiomyomas","volume":"133","author":"Chudnoff","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1185\/03007995.2010.526098","article-title":"Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding","volume":"26","author":"Lukes","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jmig.2021.04.009","article-title":"A systematic review of the treatment of uterine myomas using transcervical ultrasound-guided radiofrequency ablation with the Sonata system","volume":"28","author":"Arnreiter","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","article-title":"Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"Berman","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijgo.2013.11.012","article-title":"Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy","volume":"125","author":"Brucker","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-0035-1545931","article-title":"Radiofrequency volumetric thermal ablation of fibroids and laparoscopic myomectomy: long-term follow-up from a randomized trial","volume":"75","author":"Hahn","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/CEOR.S155038","article-title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","volume":"10","author":"Rattray","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/gyn.2020.0021","article-title":"Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata","volume":"36","author":"Lukes","year":"2020","journal-title":"J Gynecol Surg"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/gyn.2018.0051","article-title":"Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY study","volume":"35","author":"Garza-Leal","year":"2019","journal-title":"J Gynecol Surg"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jmig.2021.09.335","article-title":"Radiofrequency ablation of uterine fibroids and pregnancy outcomes: an updated review of the literature [abstract]","volume":"28","author":"Polin","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jmig.2019.06.009","article-title":"Case series of reproductive outcomes after laparoscopic radiofrequency ablation of symptomatic myomas","volume":"27","author":"Berman","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/gyn.2021.0136","article-title":"Pregnancy outcomes after transcervical radiofrequency ablation of uterine fibroids with the Sonata system","volume":"38","author":"Christoffel","year":"2022","journal-title":"J Gynecol Surg"},{"key":"R34-20260916","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1914735","article-title":"Uterine-artery embolization or myomectomy for uterine fibroids","volume":"383","author":"Manyonda","year":"2020","journal-title":"N Engl J Med"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1089\/jwh.2017.6752","article-title":"Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids","volume":"27","author":"Davis","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12905-022-01627-y","article-title":"Comparison of two invasive non-surgical treatment options for uterine myomas: uterine artery embolization and magnetic resonance guided high intensity focused ultrasound\u2014systematic review","volume":"22","author":"Yerezhepbayeva","year":"2022","journal-title":"BMC Womens Health"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.ajog.2018.10.032","article-title":"FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery","volume":"220","author":"Laughlin-Tommaso","year":"2019","journal-title":"Am J Obstet Gynecol"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000005461","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:56Z","timestamp":1789556516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005196","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"2022-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}